MedCapital Fund
C2 Capital Partners buy-and-build fund in Portuguese private hospitals and clinics; closed to new subscriptions since 2023.
Managed by C2 Capital Partners · Rua Mouzinho da Silveira 23, 1250-166 Lisbon, Portugal
Key facts
For US investors
- US investors accepted
- —
- PFIC status
- —
- Annual QEF statements
- —
- IRA / 401(k) route
- —
No public information; the fund is closed to new subscriptions.
Fees & costs
Performance
No audited performance data is publicly available for this fund yet. We only show returns we can trace to fund reporting — never marketing projections presented as track record.
Documents
No public fund documents located yet. We can request the current prospectus and KID directly from the manager — book a consultation and we will walk you through them.
Data transparency
Researched Jul 7, 2026 · every fact carries its source
Still researching
- Management fee
- Performance fee
- Lock-up period
- CMVM registration
- US investor acceptance
- Golden Visa eligibility
- ISIN
- Fund size
- Inception date
- NAV frequency
- Hurdle rate
- Subscription fee
- Redemption fee
- Custodian
- Auditor
- Distribution policy
- PFIC status
- QEF reporting
- IRA/401(k) eligibility
- Portfolio allocation
Sources
- 1MedCapital — Nomad Gate profile (subscription ended) — Nomad Gate (aggregator), accessed Jul 7, 2026
- 2MedCapital Fund profile (target size, timeline, strategy) — Portugal Funds Golden Visa (aggregator), accessed Jul 7, 2026
- 3CMS advises the FCR fund C2 MedCapital (Hospital de Loulé acquisition; located via search, summary reviewed 2026-07-07) — Iberian Lawyer (press), accessed Jul 7, 2026
Research summary
Compiled from the sources cited on this page — a factual summary, not a recommendation or rating.
MedCapital (C2 MedCapital, FCR) is a closed-end healthcare private equity fund managed by C2 Capital Partners, a Lisbon growth-investment firm founded in 2009. The thesis was buy-and-build in Portuguese private hospitals and clinics — targeting roughly seven investments and €50 million in regions underserved by the big private healthcare groups — led by operating partners with long experience at a market-leading private healthcare operator. The fund has been genuinely active: it took a 60% majority stake in the Hospital de Loulé group in the Algarve and closed a deal for Hospital Privado das Beiras in December 2025.
The fund is closed to new investors. Nomad Gate records the subscription deadline as 30 May 2023, while another aggregator cites December 2021 — either way, subscriptions ended before the October 2023 Golden Visa rule change, whose effect on a hospital-heavy strategy (with its inherent property component) was never publicly clarified. The fund is now expected to be in or near its divestment phase (from 2026, maturity around 2030).
Public disclosure of economics is minimal — no fees, registration numbers or NAV are available, and C2 Capital's website blocks automated access — so this profile relies on aggregator records and press coverage of portfolio transactions. Retained in the database for reference.
Suited for
- ·Not available — the fund closed to new subscriptions in 2023
- ·Existing investors or researchers tracking Portuguese healthcare PE consolidation
Risk factors
- ·Hospital and clinic buyouts carry an inherent real-estate component — post-2023 Golden Visa eligibility was never clarified
- ·The 20% projected annual return is promoter marketing, not an audited figure
- ·No public fees, registration or performance data; closed-end structure with exit dependent on trade sales
Listed for completeness, drawn from fund materials and public sources — not an assessment. How much weight any factor deserves depends on your own situation and risk appetite.
Tom Brooks
Founding Partner & CEO
Talk through MedCapital Fund and how it fits your Golden Visa plan — independent guidance, no obligation.
Book a free consultationor email hello@rootsglobal.com
